{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:11:14Z","timestamp":1790161874235,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T00:00:00Z","timestamp":1543795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T00:00:00Z","timestamp":1543795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41591-018-0262-9","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T09:29:42Z","timestamp":1542878982000},"page":"130-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Wiskott\u2013Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma"],"prefix":"10.1038","volume":"25","author":[{"given":"Matteo","family":"Menotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4122-701X","authenticated-orcid":false,"given":"Chiara","family":"Ambrogio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taek-Chin","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth H.","family":"Cassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Compagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dall\u2019Olio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio G.","family":"Minero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Poggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4144-2799","authenticated-orcid":false,"given":"Geeta Geeta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Patrucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mastini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Choudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Pich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Piva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Giliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mologni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton K.","family":"Collings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-5985","authenticated-orcid":false,"given":"Cigall","family":"Kadoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Gambacorti-Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-0262","authenticated-orcid":false,"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines M.","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-1431","authenticated-orcid":false,"given":"Claudia","family":"Voena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-8531","authenticated-orcid":false,"given":"Roberto","family":"Chiarle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"key":"262_CR1","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","volume":"125","author":"KE Sullivan","year":"1994","unstructured":"Sullivan, K. E., Mullen, C. A., Blaese, R. M. & Winkelstein, J. A. A multiinstitutional survey of the Wiskott\u2013Aldrich syndrome. J. Pediatr. 125, 876\u2013885 (1994).","journal-title":"J. Pediatr."},{"key":"262_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1074-7613(02)00268-6","volume":"16","author":"IM Anton","year":"2002","unstructured":"Anton, I. M. et al. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity 16, 193\u2013204 (2002).","journal-title":"Immunity"},{"key":"262_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1073\/pnas.0610275104","volume":"104","author":"MA de la Fuente","year":"2007","unstructured":"de la Fuente, M. A. et al. WIP is a chaperone for Wiskott\u2013Aldrich syndrome protein (WASP). Proc. Natl Acad. Sci. USA 104, 926\u2013931 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"262_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12026-008-8086-1","volume":"44","author":"N Ramesh","year":"2009","unstructured":"Ramesh, N. & Geha, R. Recent advances in the biology of WASP and WIP. Immunol. Res. 44, 99\u2013111 (2009).","journal-title":"Immunol. Res."},{"key":"262_CR5","doi-asserted-by":"publisher","first-page":"14671","DOI":"10.1073\/pnas.94.26.14671","volume":"94","author":"N Ramesh","year":"1997","unstructured":"Ramesh, N., Anton, I. M., Hartwig, J. H. & Geha, R. S. WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc. Natl Acad. Sci. USA 94, 14671\u201314676 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"262_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/20726","volume":"399","author":"N Abdul-Manan","year":"1999","unstructured":"Abdul-Manan, N. et al. Structure of Cdc42 in complex with the GTPase-binding domain of the \u2018Wiskott\u2013Aldrich syndrome\u2019 protein. Nature 399, 379\u2013383 (1999).","journal-title":"Nature"},{"key":"262_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nri2724","volume":"10","author":"AJ Thrasher","year":"2010","unstructured":"Thrasher, A. J. & Burns, S. O. WASP: a key immunological multitasker. Nat. Rev. Immunol. 10, 182\u2013192 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"262_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/nyas.12049","volume":"1285","author":"MJ Massaad","year":"2013","unstructured":"Massaad, M. J., Ramesh, N. & Geha, R. S. Wiskott\u2013Aldrich syndrome: a comprehensive review. Ann. N. Y. Acad. Sci. 1285, 26\u201343 (2013).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"262_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1074-7613(00)80590-7","volume":"9","author":"SB Snapper","year":"1998","unstructured":"Snapper, S. B. et al. Wiskott\u2013Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9, 81\u201391 (1998).","journal-title":"Immunity"},{"key":"262_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","volume":"117","author":"HD Ochs","year":"2006","unstructured":"Ochs, H. D. & Thrasher, A. J. The Wiskott\u2013Aldrich syndrome. J. Allergy Clin. Immunol. 117, 725\u2013738 (2006). quiz 739.","journal-title":"J. Allergy Clin. Immunol."},{"key":"262_CR11","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1182\/blood-2011-09-379412","volume":"119","author":"M Recher","year":"2012","unstructured":"Recher, M. et al. B cell-intrinsic deficiency of the Wiskott\u2013Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice. Blood 119, 2819\u20132828 (2012).","journal-title":"Blood"},{"key":"262_CR12","first-page":"1","volume":"29","author":"RL Boddicker","year":"2016","unstructured":"Boddicker, R. L., Razidlo, G. L. & Feldman, A. L. Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas. Small GTPases 29, 1\u20137 (2016).","journal-title":"Small GTPases"},{"key":"262_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/blood-2014-12-614503","volume":"127","author":"I Scarfo","year":"2016","unstructured":"Scarfo, I. et al. Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts. Blood 127, 221\u2013232 (2016).","journal-title":"Blood"},{"key":"262_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","volume":"27","author":"R Crescenzo","year":"2015","unstructured":"Crescenzo, R. et al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell. 27, 516\u2013532 (2015).","journal-title":"Cancer Cell."},{"key":"262_CR15","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar, E. R. et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124, 1473\u20131480 (2014).","journal-title":"Blood"},{"key":"262_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1182\/blood-2016-05-717793","volume":"129","author":"MT Werner","year":"2017","unstructured":"Werner, M. T., Zhao, C., Zhang, Q. & Wasik, M. A. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target. Blood 129, 823\u2013831 (2017).","journal-title":"Blood"},{"key":"262_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.2916","volume":"46","author":"HY Yoo","year":"2014","unstructured":"Yoo, H. Y. et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 371\u2013375 (2014).","journal-title":"Nat. Genet."},{"key":"262_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto, M. et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 171\u2013175 (2014).","journal-title":"Nat. Genet."},{"key":"262_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng.2873","volume":"46","author":"T Palomero","year":"2014","unstructured":"Palomero, T. et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat. Genet. 46, 166\u2013170 (2014).","journal-title":"Nat. Genet."},{"key":"262_CR20","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1073\/pnas.1608839114","volume":"114","author":"F Abate","year":"2017","unstructured":"Abate, F. et al. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proc. Natl Acad. Sci. USA 114, 764\u2013769 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"262_CR21","doi-asserted-by":"publisher","first-page":"8899","DOI":"10.1158\/0008-5472.CAN-08-2568","volume":"68","author":"C Ambrogio","year":"2008","unstructured":"Ambrogio, C. et al. The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation. Cancer Res. 68, 8899\u20138907 (2008).","journal-title":"Cancer Res."},{"key":"262_CR22","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1038\/sj.onc.1210921","volume":"27","author":"A Colomba","year":"2008","unstructured":"Colomba, A. et al. Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas. Oncogene 27, 2728\u20132736 (2008).","journal-title":"Oncogene"},{"key":"262_CR23","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1182\/blood-2015-11-683052","volume":"127","author":"R Choudhari","year":"2016","unstructured":"Choudhari, R. et al. Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice. Blood 127, 1297\u20131306 (2016).","journal-title":"Blood"},{"key":"262_CR24","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390 (2016).","journal-title":"Blood"},{"key":"262_CR25","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2002-05-1343","volume":"101","author":"R Chiarle","year":"2003","unstructured":"Chiarle, R. et al. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood 101, 1919\u20131927 (2003).","journal-title":"Blood"},{"key":"262_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1084\/jem.20110896","volume":"209","author":"G Lanzi","year":"2012","unstructured":"Lanzi, G. et al. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP. J. Exp. Med. 209, 29\u201334 (2012).","journal-title":"J. Exp. Med."},{"key":"262_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jaci.2016.08.036","volume":"139","author":"H Al-Mousa","year":"2017","unstructured":"Al-Mousa, H. et al. Hematopoietic stem cell transplantation corrects WIP deficiency. J. Allergy Clin. Immunol. 139, 1039\u20131040 e1034 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"262_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/01.all.0000191243.25757.ce","volume":"5","author":"LD Notarangelo","year":"2005","unstructured":"Notarangelo, L. D., Notarangelo, L. D. & Ochs, H. D. WASP and the phenotypic range associated with deficiency. Curr. Opin. Allergy. Clin. Immunol. 5, 485\u2013490 (2005).","journal-title":"Curr. Opin. Allergy. Clin. Immunol."},{"key":"262_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0092-8674(05)80020-0","volume":"81","author":"CS Hill","year":"1995","unstructured":"Hill, C. S., Wynne, J. & Treisman, R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81, 1159\u20131170 (1995).","journal-title":"Cell"},{"key":"262_CR30","doi-asserted-by":"publisher","first-page":"8611","DOI":"10.1158\/0008-5472.CAN-09-2655","volume":"69","author":"C Ambrogio","year":"2009","unstructured":"Ambrogio, C. et al. NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells. Cancer Res. 69, 8611\u20138619 (2009).","journal-title":"Cancer Res."},{"key":"262_CR31","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.celrep.2016.09.018","volume":"17","author":"MR Hassler","year":"2016","unstructured":"Hassler, M. R. et al. Insights into the pathogenesis of anaplastic large-cell lymphoma through genome-wide DNA methylation profiling. Cell Rep. 17, 596\u2013608 (2016).","journal-title":"Cell Rep."},{"key":"262_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood-2005-05-2125","volume":"107","author":"R Piva","year":"2006","unstructured":"Piva, R. et al. Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood 107, 689\u2013697 (2006).","journal-title":"Blood"},{"key":"262_CR33","doi-asserted-by":"publisher","first-page":"djt378","DOI":"10.1093\/jnci\/djt378","volume":"106","author":"C Gambacorti Passerini","year":"2014","unstructured":"Gambacorti Passerini, C. et al. Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients. J. Natl Cancer. Inst. 106, djt378 (2014).","journal-title":"J. Natl Cancer. Inst."},{"key":"262_CR34","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/nm.3930","volume":"21","author":"G Hrustanovic","year":"2015","unstructured":"Hrustanovic, G. et al. RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer. Nat. Med. 21, 1038\u20131047 (2015).","journal-title":"Nat. Med."},{"key":"262_CR35","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/eji.201646715","volume":"47","author":"E Rivers","year":"2017","unstructured":"Rivers, E. & Thrasher, A. J. Wiskott\u2013Aldrich syndrome protein: emerging mechanisms in immunity. Eur. J. Immunol. 47, 1857\u20131866 (2017).","journal-title":"Eur. J. Immunol."},{"key":"262_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm1249","volume":"11","author":"R Chiarle","year":"2005","unstructured":"Chiarle, R. et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat. Med. 11, 623\u2013629 (2005).","journal-title":"Nat. Med."},{"key":"262_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jaci.2013.03.046","volume":"132","author":"Y Watanabe","year":"2013","unstructured":"Watanabe, Y. et al. T-cell receptor ligation causes Wiskott\u2013Aldrich syndrome protein degradation and F-actin assembly downregulation. J. Allergy Clin. Immunol. 132, 648\u2013655 e641 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"262_CR38","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/onc.2016.366","volume":"36","author":"CA Murga-Zamalloa","year":"2017","unstructured":"Murga-Zamalloa, C. A. et al. NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma. Oncogene 36, 2085\u20132094 (2017).","journal-title":"Oncogene"},{"key":"262_CR39","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1096\/fj.201700179R","volume":"31","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Intersectin 2 controls actin cap formation and meiotic division in mouse oocytes through the Cdc42 pathway. FASEB J 31, 4277\u20134285 (2017).","journal-title":"FASEB J"},{"key":"262_CR40","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.194.12.1777","volume":"194","author":"MK McGavin","year":"2001","unstructured":"McGavin, M. K. et al. The intersectin 2 adaptor links Wiskott Aldrich Syndrome protein (WASp)-mediated actin polymerization to T cell antigen receptor endocytosis. J. Exp. Med. 194, 1777\u20131787 (2001).","journal-title":"J. Exp. Med."},{"key":"262_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1101\/gad.361406","volume":"20","author":"X Wu","year":"2006","unstructured":"Wu, X. et al. Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. Genes Dev. 20, 571\u2013585 (2006).","journal-title":"Genes Dev."},{"key":"262_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(SICI)1096-9896(199805)185:1<99::AID-PATH48>3.0.CO;2-L","volume":"185","author":"F Facchetti","year":"1998","unstructured":"Facchetti, F. et al. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott\u2013Aldrich syndrome. J. Pathol. 185, 99\u2013107 (1998).","journal-title":"J. Pathol."},{"key":"262_CR43","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1158\/0008-5472.CAN-14-0268","volume":"74","author":"C Martinengo","year":"2014","unstructured":"Martinengo, C. et al. ALK-dependent control of hypoxia inducible factors mediates tumor growth and metastasis. Cancer Res. 74, 6094\u2013106 (2014).","journal-title":"Cancer Res."},{"key":"262_CR44","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1172\/JCI29401","volume":"116","author":"R Piva","year":"2006","unstructured":"Piva, R. et al. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J. Clin. Invest. 116, 3171\u20133182 (2006).","journal-title":"J. Clin. Invest."},{"key":"262_CR45","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1038\/onc.2015.456","volume":"35","author":"M Ceccon","year":"2016","unstructured":"Ceccon, M. et al. Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency. Oncogene 35, 3854\u20133865 (2016).","journal-title":"Oncogene"},{"key":"262_CR46","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.celrep.2014.10.018","volume":"9","author":"DA Orlando","year":"2014","unstructured":"Orlando, D. A. et al. Quantitative ChIP-seq normalization reveals global modulation of the epigenome. Cell reports 9, 1163\u20131170 (2014).","journal-title":"Cell reports"},{"key":"262_CR47","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1126\/science.1259037","volume":"346","author":"MR Mansour","year":"2014","unstructured":"Mansour, M. R. et al. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 346, 1373\u20131377 (2014).","journal-title":"Science"},{"key":"262_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep43345","volume":"7","author":"M Manser","year":"2017","unstructured":"Manser, M. et al. ELF-MF exposure affects the robustness of epigenetic programming during granulopoiesis. Sci. Rep. 7, 43345 (2017).","journal-title":"Sci. Rep."},{"key":"262_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature11232","volume":"489","author":"RE Thurman","year":"2012","unstructured":"Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75\u201382 (2012).","journal-title":"Nature"},{"key":"262_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"262_CR51","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"262_CR52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/bib\/bbs038","volume":"14","author":"RM Kuhn","year":"2013","unstructured":"Kuhn, R. M., Haussler, D. & Kent, W. J. The UCSC genome browser and associated tools. Brief. Bioinform. 14, 144\u2013161 (2013).","journal-title":"Brief. Bioinform."},{"key":"262_CR53","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-seq (MACS). Genome. Biol. 9, R137 (2008).","journal-title":"Genome. Biol."},{"key":"262_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-284","volume":"15","author":"L Shen","year":"2014","unstructured":"Shen, L., Shao, N., Liu, X. & Nestler, E. ngs.plot: quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics 15, 284 (2014).","journal-title":"BMC Genomics"},{"key":"262_CR55","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cell.2017.12.020","volume":"172","author":"C Ambrogio","year":"2018","unstructured":"Ambrogio, C. et al. Kras dimerization impacts MEK inhibitor sensitivity and oncogenic activity of mutant KRAS. Cell 172, 857\u2013868 e815 (2018).","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1038\/s41591-026-04339-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0262-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:25:37Z","timestamp":1774020337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0262-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1038\/s41591-018-0262-9","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,3]]},"assertion":[{"value":"3 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41591-026-04339-0","URL":"https:\/\/doi.org\/10.1038\/s41591-026-04339-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}